Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Are transdermic estrogens cardioprotective?].

J E Blümel1, I Campodónico

  • 1Fundación Prosam y Facultad de Medicina, Universidad de Chile, Santiago de Chile. jeblumel@entelchile.net

Revista Medica De Chile
|June 21, 2001
PubMed
Summary

Transdermic estrogens may share cardiovascular effects with oral forms, but lack proven cardioprotective benefits. Current evidence suggests oral estrogens may be more beneficial for cardiovascular risk reduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genitourinary symptoms and sexual function in women with primary ovarian insufficiency.

Climacteric : the journal of the International Menopause Society·2024
Same author

Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study.

Climacteric : the journal of the International Menopause Society·2021
Same author

Gender differences in the prevalence of vitamin D deficiency in a southern Latin American country: a pilot study.

Climacteric : the journal of the International Menopause Society·2020
Same author

Menopausal symptoms are associated with non-adherence to highly active antiretroviral therapy in human immunodeficiency virus-infected middle-aged women.

Climacteric : the journal of the International Menopause Society·2019
Same author

Association between high levels of gynoid fat and the increase of bone mineral density in women.

Climacteric : the journal of the International Menopause Society·2019
Same author

Muscle health in Hispanic women. REDLINC VIII.

Climacteric : the journal of the International Menopause Society·2019

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Pharmacology

Context:

  • Estrogen therapy is used for various conditions, with cardiovascular effects being a key consideration.
  • Both oral and transdermic estrogen formulations are available, each with distinct pharmacokinetic profiles.
  • Understanding the cardiovascular impact of different estrogen delivery methods is crucial for patient care.

Purpose:

  • To evaluate the cardioprotective potential of transdermic estrogens compared to oral estrogens.
  • To review existing animal and human studies on the cardiovascular effects of transdermic estrogen therapy.
  • To determine if transdermic estrogens offer antiatherogenic benefits.

Summary:

  • Transdermic estrogens exhibit cardiovascular effects similar to oral estrogens.
  • Unlike oral estrogens, which show antiatherogenic effects in animal studies, transdermic estrogens yield contradictory results.
  • There is a lack of robust evidence, from animal or human studies, demonstrating cardioprotective effects of transdermic estrogens.

Impact:

  • Current knowledge suggests oral estrogens may be preferred for cardiovascular risk improvement.
  • Further extensive clinical trials are necessary to definitively establish the cardioprotective role of transdermic estrogens.
  • This research highlights the need for nuanced understanding of estrogen formulations and their cardiovascular implications.

Related Experiment Videos